Industry: Chemical & Material
Published Date: 2025-01-13
Pages: 90 Pages
Report ld: 3471120
Request Sample
Customized Report
Iodixanol API Market Size(US$)

CAGR 2025-2031
4.4%
Market Size,2031
USD 438
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Iodixanol API was estimated to be worth US$ 325 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
The market for Iodixanol API is driven by its application in radiology and diagnostic imaging. Iodixanol provides high-quality and clear imaging results, making it valuable in various medical procedures. The demand for effective and safe contrast agents contributes to the growth of this market.
This report aims to provide a comprehensive presentation of the global market for Iodixanol API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Iodixanol API by region & country, by Type, and by Application.
The Iodixanol API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iodixanol API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Iodixanol API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Iodixanol API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Iodixanol API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Iodixanol API Product Introduction
1.2 Global Iodixanol API Market Size Forecast
1.2.1 Global Iodixanol API Sales Value (2020-2031)
1.2.2 Global Iodixanol API Sales Volume (2020-2031)
1.2.3 Global Iodixanol API Sales Price (2020-2031)
1.3 Iodixanol API Market Trends & Drivers
1.3.1 Iodixanol API Industry Trends
1.3.2 Iodixanol API Market Drivers & Opportunity
1.3.3 Iodixanol API Market Challenges
1.3.4 Iodixanol API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Iodixanol API Players Revenue Ranking (2024)
2.2 Global Iodixanol API Revenue by Company (2020-2025)
2.3 Global Iodixanol API Players Sales Volume Ranking (2024)
2.4 Global Iodixanol API Sales Volume by Company Players (2020-2025)
2.5 Global Iodixanol API Average Price by Company (2020-2025)
2.6 Key Manufacturers Iodixanol API Manufacturing Base and Headquarters
2.7 Key Manufacturers Iodixanol API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Iodixanol API
2.9 Iodixanol API Market Competitive Analysis
2.9.1 Iodixanol API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Iodixanol API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iodixanol API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Original Drug
3.1.2 Generic Drug
3.2 Global Iodixanol API Sales Value by Type
3.2.1 Global Iodixanol API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Iodixanol API Sales Value, by Type (2020-2031)
3.2.3 Global Iodixanol API Sales Value, by Type (%) (2020-2031)
3.3 Global Iodixanol API Sales Volume by Type
3.3.1 Global Iodixanol API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Iodixanol API Sales Volume, by Type (2020-2031)
3.3.3 Global Iodixanol API Sales Volume, by Type (%) (2020-2031)
3.4 Global Iodixanol API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Iodixanol API Sales Value by Application
4.2.1 Global Iodixanol API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Iodixanol API Sales Value, by Application (2020-2031)
4.2.3 Global Iodixanol API Sales Value, by Application (%) (2020-2031)
4.3 Global Iodixanol API Sales Volume by Application
4.3.1 Global Iodixanol API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Iodixanol API Sales Volume, by Application (2020-2031)
4.3.3 Global Iodixanol API Sales Volume, by Application (%) (2020-2031)
4.4 Global Iodixanol API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Iodixanol API Sales Value by Region
5.1.1 Global Iodixanol API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Iodixanol API Sales Value by Region (2020-2025)
5.1.3 Global Iodixanol API Sales Value by Region (2026-2031)
5.1.4 Global Iodixanol API Sales Value by Region (%), (2020-2031)
5.2 Global Iodixanol API Sales Volume by Region
5.2.1 Global Iodixanol API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Iodixanol API Sales Volume by Region (2020-2025)
5.2.3 Global Iodixanol API Sales Volume by Region (2026-2031)
5.2.4 Global Iodixanol API Sales Volume by Region (%), (2020-2031)
5.3 Global Iodixanol API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Iodixanol API Sales Value, 2020-2031
5.4.2 North America Iodixanol API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Iodixanol API Sales Value, 2020-2031
5.5.2 Europe Iodixanol API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Iodixanol API Sales Value, 2020-2031
5.6.2 Asia Pacific Iodixanol API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Iodixanol API Sales Value, 2020-2031
5.7.2 South America Iodixanol API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Iodixanol API Sales Value, 2020-2031
5.8.2 Middle East & Africa Iodixanol API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Iodixanol API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Iodixanol API Sales Value
6.2.1 Key Countries/Regions Iodixanol API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Iodixanol API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Iodixanol API Sales Value, 2020-2031
6.3.2 United States Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Iodixanol API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Iodixanol API Sales Value, 2020-2031
6.4.2 Europe Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Iodixanol API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Iodixanol API Sales Value, 2020-2031
6.5.2 China Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Iodixanol API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Iodixanol API Sales Value, 2020-2031
6.6.2 Japan Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Iodixanol API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Iodixanol API Sales Value, 2020-2031
6.7.2 South Korea Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Iodixanol API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Iodixanol API Sales Value, 2020-2031
6.8.2 Southeast Asia Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Iodixanol API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Iodixanol API Sales Value, 2020-2031
6.9.2 India Iodixanol API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Iodixanol API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Information
7.1.2 GE Healthcare Introduction and Business Overview
7.1.3 GE Healthcare Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GE Healthcare Iodixanol API Product Offerings
7.1.5 GE Healthcare Recent Development
7.2 Hengrui Medicine
7.2.1 Hengrui Medicine Company Information
7.2.2 Hengrui Medicine Introduction and Business Overview
7.2.3 Hengrui Medicine Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Hengrui Medicine Iodixanol API Product Offerings
7.2.5 Hengrui Medicine Recent Development
7.3 Daiichi Sankyo
7.3.1 Daiichi Sankyo Company Information
7.3.2 Daiichi Sankyo Introduction and Business Overview
7.3.3 Daiichi Sankyo Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Daiichi Sankyo Iodixanol API Product Offerings
7.3.5 Daiichi Sankyo Recent Development
7.4 YRPG
7.4.1 YRPG Company Information
7.4.2 YRPG Introduction and Business Overview
7.4.3 YRPG Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 YRPG Iodixanol API Product Offerings
7.4.5 YRPG Recent Development
7.5 BeiLu Pharma
7.5.1 BeiLu Pharma Company Information
7.5.2 BeiLu Pharma Introduction and Business Overview
7.5.3 BeiLu Pharma Iodixanol API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 BeiLu Pharma Iodixanol API Product Offerings
7.5.5 BeiLu Pharma Recent Development
8 Industry Chain Analysis
8.1 Iodixanol API Industrial Chain
8.2 Iodixanol API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Iodixanol API Sales Model
8.5.2 Sales Channel
8.5.3 Iodixanol API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Iodixanol API was estimated to be worth US$ 338 million in 2025 and is projected to reach US$ 455 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 123
USD 3950.00
(Single User License)
The global Iodixanol API market was valued at US$ 338 million in 2025 and is anticipated to reach US$ 455 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 121
USD 2900.00
(Single User License)
The global Iodixanol API market size was US$ 325 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 70
USD 4250.00
(Single User License)
The global Iodixanol API market is projected to grow from US$ 325 million in 2024 to US$ 438 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 110
USD 4900.00
(Single User License)
The global market for Iodixanol API was valued at US$ 325 million in the year 2024 and is projected to reach a revised size of US$ 438 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published Date: 2025-01-16
Pages: 77
USD 2900.00
(Single User License)
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
Published Date: 2024-04-12
Pages: 93
USD 4900.00
(Single User License)
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
Published Date: 2024-01-17
Pages: 92
USD 2900.00
(Single User License)
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
Published Date: 2024-01-07
Pages: 97
USD 3950.00
(Single User License)
The global market for Iodixanol API was estimated to be worth US$ 338 million in 2025 and is projected to reach US$ 455 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-06-16
Pages: 123
The global Iodixanol API market was valued at US$ 338 million in 2025 and is anticipated to reach US$ 455 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-04-18
Pages: 121
The global Iodixanol API market size was US$ 325 million in 2024 and is forecast to a readjusted size of US$ 438 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 70
The global Iodixanol API market is projected to grow from US$ 325 million in 2024 to US$ 438 million by 2031, at a CAGR of 4.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 110
The global market for Iodixanol API was valued at US$ 325 million in the year 2024 and is projected to reach a revised size of US$ 438 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published: 2025-01-16
Pages: 77
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
Published: 2024-04-12
Pages: 93
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
Published: 2024-01-17
Pages: 92
Iodixanol is an active pharmaceutical ingredient (API) used as a non-ionic X-ray contrast medium in medical imaging.
Published: 2024-01-07
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now